140 related articles for article (PubMed ID: 37439628)
1. Vanadium-Substituted Polyoxometalates Regulate Prion Protein Fragment 106-126 Misfolding by an Oxidation Strategy.
Li B; Xu C; Lv Y; Liu G; Sun X; Sun Z; Xu X; Chen W; He L; Song YF
ACS Appl Mater Interfaces; 2023 Jul; 15(29):34497-34504. PubMed ID: 37439628
[TBL] [Abstract][Full Text] [Related]
2. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.
Younan ND; Nadal RC; Davies P; Brown DR; Viles JH
J Biol Chem; 2012 Aug; 287(34):28263-75. PubMed ID: 22654104
[TBL] [Abstract][Full Text] [Related]
3. Surface charge of polyoxometalates modulates polymerization of the scrapie prion protein.
Wille H; Shanmugam M; Murugesu M; Ollesch J; Stubbs G; Long JR; Safar JG; Prusiner SB
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3740-5. PubMed ID: 19223590
[TBL] [Abstract][Full Text] [Related]
4. Roles of methionine oxidation in E200K prion protein misfolding: Implications for the mechanism of pathogenesis in E200K linked familial Creutzfeldt-Jakob disease.
Wang Z; Feng B; Xiao G; Zhou Z
Biochim Biophys Acta; 2016 Apr; 1864(4):346-58. PubMed ID: 26779934
[TBL] [Abstract][Full Text] [Related]
5. General Method of Quantifying the Extent of Methionine Oxidation in the Prion Protein.
Silva CJ; Erickson-Beltran ML
J Am Soc Mass Spectrom; 2023 Feb; 34(2):255-263. PubMed ID: 36608322
[TBL] [Abstract][Full Text] [Related]
6. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
Elmallah MI; Borgmeyer U; Betzel C; Redecke L
Prion; 2013; 7(5):404-11. PubMed ID: 24121542
[TBL] [Abstract][Full Text] [Related]
7. Methionine oxidation within the prion protein.
Bettinger J; Ghaemmaghami S
Prion; 2020 Dec; 14(1):193-205. PubMed ID: 32744136
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aggregation behavior and neurotoxicity of prion neuropeptides by platinum complexes.
Wang X; Cui M; Zhao C; He L; Zhu D; Wang B; Du W
Inorg Chem; 2014 May; 53(10):5044-54. PubMed ID: 24787240
[TBL] [Abstract][Full Text] [Related]
9. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
10. Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism.
He L; Wang X; Zhu D; Zhao C; Du W
Metallomics; 2015 Dec; 7(12):1562-72. PubMed ID: 26444976
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of sesquiterpene lactones on the aggregation and cytotoxicity of prion neuropeptide.
Huo Y; Huang X; Wang Y; Zhao C; Zheng T; Du W
Biochimie; 2023 Aug; 211():131-140. PubMed ID: 36963557
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
13. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
14.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
15. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
16. Impact of pyridine-2-carboxaldehyde-derived aroylhydrazones on the copper-catalyzed oxidation of the M112A PrP
Cukierman DS; Bodnár N; Evangelista BN; Nagy L; Kállay C; Rey NA
J Biol Inorg Chem; 2019 Dec; 24(8):1231-1244. PubMed ID: 31401689
[TBL] [Abstract][Full Text] [Related]
17. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
[TBL] [Abstract][Full Text] [Related]
19. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
[TBL] [Abstract][Full Text] [Related]
20. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
